FtsZ is a crucial prokaryotic protein involved in bacterial cell replication. It recently arose as a promising target in the search for antimicrobial agents able to fight antimicrobial resistance. In this work, going on with our structure‐activity relationship (SAR) study, we developed variously 7‐substituted 1,4‐benzodioxane compounds, linked to the 2,6‐difluorobenzamide by a methylenoxy bridge. Compounds exhibit promising antibacterial activities not only against multidrug‐resistant Staphylococcus aureus, but also on mutated Escherichia coli strains, thus enlarging their spectrum of action toward Gram‐negative bacteria as well. Computational studies elucidated, through a validated FtsZ binding protocol, the structural features of new promising derivatives as FtsZ inhibitors.
|Titolo:||Benzodioxane‐Benzamides as Antibacterial Agents : Computational and SAR Studies to Evaluate the Influence of the 7‐Substitution in FtsZ Interaction|
STRANIERO, VALENTINA (Corresponding)
|Parole Chiave:||FtsZinhibition; 1,4-benzodioxane-2,6-difluorobenzamide; Mutated E. coli; molecular modelling; cavitydetection|
|Settore Scientifico Disciplinare:||Settore CHIM/08 - Chimica Farmaceutica|
|Data di pubblicazione:||21-nov-2019|
|Digital Object Identifier (DOI):||http://dx.doi.org/10.1002/cmdc.201900537|
|Appare nelle tipologie:||01 - Articolo su periodico|